Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry ...
Lucinda Smith Appointed as Chief Safety Product Officer at ArisGlobal
Boston, Massachusetts, USA – May 15, 2025 – ArisGlobal, an ...
ArisGlobal Introduces Shared Success Model to Guarantee Automation Return on Investment
With the Shared Success Model, ArisGlobal delivers more than just technology — it offers a tested path to operational transformation
ArisGlobal Launches New NavaX Agent – MedDRA Coding Powered by Agentic AI
A Breakthrough in AI-Powered Pharmacovigilance, the Agent will transform MedDRA coding with context-aware, autonomous decision-making.
Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform
Another top-tier pharmaceutical company has chosen LifeSphere Advanced Signals.
ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs
At Breakthrough 2025 ArisGlobal unveiled LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs.
Fifth Global Pharma Company Selects LifeSphere NavaX to Drive AI-Powered Case Processing
This marks the fifth leading pharma organization to adopt LifeSphere NavaX, reinforcing the industry’s trust in AI-driven innovation for drug safety and regulatory operations.
ArisGlobal Announces Strategic Partnership with Celegence to Empower Life Sciences Regulatory Transformation
       Boston, Massachusetts, USA ...
ArisGlobal Announces Breakthrough 2025 Speaker Lineup
Over 50 executive speakers and more than 200 expected attendees will explore "AI In Action," advancing automation, GenAI, large language models, and real-world data across pharmacovigilance and regulatory operations
LifeSphere MultiVigilance Expands to Support Safety Compliance for Medical Devices with Automated Capabilities
These practices are essential For societal benefits including enhanced patient safety.
